Feprosidnine
Feprosidnine chemical structure.png
Clinical data
ATC code
  • none
Identifiers
  • 5-Imino-3-(1-phenylpropan-2-yl)-5H-1,2,3-oxadiazol-3-ium-2-ide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC11H13N3O
Molar mass203.245 g·mol−1
3D model (JSmol)
  • n1oc([NH-])c[n+]1C(Cc2ccccc2)C
  • InChI=1S/C11H13N3O/c1-9(14-8-11(12)15-13-14)7-10-5-3-2-4-6-10/h2-6,8-9,12H,7H2,1H3 checkY
  • Key:HFLCEELTJROKMJ-UHFFFAOYSA-N checkY
  (verify)

Feprosidnine (Sydnophen) is a stimulant drug which was developed in the USSR in the 1970s.[1][2] It is structurally related to another Russian drug mesocarb but unlike mesocarb, was withdrawn earlier from production. In comparison with mesocarb it has own antidepressant activity, which makes it useful in treating depressions. Indications of feprosidnine included apathic, asthenic depressions, fatigue, apathic syndrome, narcolepsy and other similar conditions. Therapeutic range of doses: 10-50mg a day. Sydnophen has multiple mechanisms of action, the relative importance of which has not been clearly established. Effects on the body include reversible monoamine oxidase inhibition, cholinergic,[3] adrenergic,[4] opioid[5] and nitric oxide donating[6] actions, all of which may contribute to its pharmacological effects to some extent.

Chemistry

Feprosidnine is a mesoionic sydnone imine.

References

  1. ^ Veksler IG, Riabukha VN, Balitskiĭ KP, Al'tshuler RA, Mashkovskiĭ MD (1980). "[Immunostimulating and antitumor action of psychotropic preparations of the sydnonimine series]". Farmakologiia I Toksikologiia (in Russian). 43 (3): 349–52. PMID 7449977.
  2. ^ Koniaeva EI, Beketov AI (1987). "[Effect of caffeine and sidnofen on the blood supply of the brain, kidneys and hindlimbs during antiorthostatism]". Farmakologiia I Toksikologiia (in Russian). 50 (3): 39–42. PMID 3609274.
  3. ^ Samonina GE, Mandriko EV (April 1989). "[Peripheral cholinolytic action--one of the effects of sidnofen]". Biulleten' Eksperimental'noi Biologii I Meditsiny (in Russian). 107 (4): 449–51. PMID 2720163.
  4. ^ Babskaia NE (1992). "[Sidnofen-dependent pre- and postsynaptic activation of peripheral adrenergic transmission]". Eksperimental'naia i Klinicheskaia Farmakologiia (in Russian). 55 (5): 21–5. PMID 1339046.
  5. ^ D'iakonova TL, Samonina GE (1994). "[The naloxone-dependent effects of the psychostimulant sidnofen: a study on identified neurons of the snail]". Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova (in Russian). 44 (4–5): 786–95. PMID 7810220.
  6. ^ Arzamastsev AP, Severina IS, Grigor'ev NB, Granik VG (2003). "[Exogenous donors of nitric oxide and inhibitors of NO-synthase (chemical aspects)]". Vestnik Rossiiskoi Akademii Meditsinskikh Nauk (in Russian) (12): 88–95. PMID 14724985.